Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Gastroenteropancreatic neuroendocrine tumours.

Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A.

Lancet Oncol. 2008 Jan;9(1):61-72. doi: 10.1016/S1470-2045(07)70410-2. Review.

PMID:
18177818
2.

Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.

Appetecchia M, Baldelli R.

J Exp Clin Cancer Res. 2010 Mar 2;29:19. doi: 10.1186/1756-9966-29-19. Review.

3.

Neuroendocrine tumors of the gastro-entero-pancreatic system.

Massironi S, Sciola V, Peracchi M, Ciafardini C, Spampatti MP, Conte D.

World J Gastroenterol. 2008 Sep 21;14(35):5377-84. Review.

4.

Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.

Oberg KE, Reubi JC, Kwekkeboom DJ, Krenning EP.

Gastroenterology. 2010 Sep;139(3):742-53, 753.e1. doi: 10.1053/j.gastro.2010.07.002. Epub 2010 Jul 13. Review.

PMID:
20637207
5.

[Gastroenteropancreatic neuroendocrine tumours (carcinoid tumours): definition, clinical aspects, diagnosis and therapy].

Bodelier AG, Haak HR.

Ned Tijdschr Geneeskd. 2006 Aug 26;150(34):1868-72. Review. Dutch.

PMID:
16970007
6.

The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.

Schimmack S, Svejda B, Lawrence B, Kidd M, Modlin IM.

Langenbecks Arch Surg. 2011 Mar;396(3):273-98. doi: 10.1007/s00423-011-0739-1. Epub 2011 Jan 28. Review.

PMID:
21274559
7.

[New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].

Rubello D, Rufini V, De Carlo E, Martini C, Calcagni ML, Sicolo N, Troncone L, Casara D.

Minerva Endocrinol. 2003 Dec;28(4):259-96. Review. Italian.

PMID:
14752399
8.

Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours: literature review, clinical recommendations and schedules.

Massironi S, Conte D, Rossi RE.

Scand J Gastroenterol. 2016;51(5):513-23. doi: 10.3109/00365521.2015.1115117. Epub 2015 Nov 25. Review.

PMID:
26605828
9.

A tale of two tumors: treating pancreatic and extrapancreatic neuroendocrine tumors.

Halperin DM, Kulke MH, Yao JC.

Annu Rev Med. 2015;66:1-16. doi: 10.1146/annurev-med-061813-012908. Epub 2014 Oct 17. Review.

PMID:
25341008
10.

Nutrition and gastroenteropancreatic neuroendocrine tumors.

Go VL, Srihari P, Kamerman Burns LA.

Endocrinol Metab Clin North Am. 2010 Dec;39(4):827-37. doi: 10.1016/j.ecl.2010.08.003. Review.

PMID:
21095548
11.

Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours.

Modlin IM, Pavel M, Kidd M, Gustafsson BI.

Aliment Pharmacol Ther. 2010 Jan 15;31(2):169-88. doi: 10.1111/j.1365-2036.2009.04174.x. Epub 2009 Oct 21. Review.

12.

Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.

Fazio N, Milione M.

Cancer Treat Rev. 2016 Nov;50:61-67. doi: 10.1016/j.ctrv.2016.08.006. Epub 2016 Aug 28. Review.

PMID:
27636009
13.

Medical treatment of neuroendocrine tumours.

Weber HC.

Curr Opin Endocrinol Diabetes Obes. 2013 Feb;20(1):27-31. doi: 10.1097/MED.0b013e32835c034f. Review.

PMID:
23221494
14.

Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel.

Poncet G, Faucheron JL, Walter T.

World J Gastroenterol. 2010 Apr 14;16(14):1696-706. Review.

15.

Neuroendocrine gastrointestinal tumours.

Oberg K.

Ann Oncol. 1996 Jul;7(5):453-63. Review.

PMID:
8839899
16.

An update on gastroenteropancreatic neuroendocrine tumors.

Cives M, Strosberg J.

Oncology (Williston Park). 2014 Sep;28(9):749-56, 758. Review.

PMID:
25224471
17.

Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives.

Baldelli R, Barnabei A, Rizza L, Isidori AM, Rota F, Di Giacinto P, Paoloni A, Torino F, Corsello SM, Lenzi A, Appetecchia M.

Front Endocrinol (Lausanne). 2014 Feb 7;5:7. doi: 10.3389/fendo.2014.00007. eCollection 2014. Review.

18.

Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).

Desai KK, Khan MS, Toumpanakis C, Caplin ME.

Minerva Gastroenterol Dietol. 2009 Dec;55(4):425-43. Review.

PMID:
19942827
19.

The diagnosis and medical management of advanced neuroendocrine tumors.

Kaltsas GA, Besser GM, Grossman AB.

Endocr Rev. 2004 Jun;25(3):458-511. Review.

PMID:
15180952
20.

Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours.

Srirajaskanthan R, Toumpanakis C, Meyer T, Caplin ME.

Aliment Pharmacol Ther. 2009 Jun 1;29(11):1143-54. doi: 10.1111/j.1365-2036.2009.03988.x. Epub 2009 Mar 2. Review.

Supplemental Content

Support Center